{
    "code": "01019330",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01019330",
    "time": "2017-07-21 15:38:42",
    "許可證字號": "衛署藥製字第019330號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/12\/12",
    "註銷理由": "自請註銷",
    "有效日期": "103\/11\/13",
    "發證日期": "68\/11\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101933009",
    "中文品名": "&quot;溫士頓&quot; 僂麻鎮注射液",
    "英文品名": "RENMATIN INJECTION &quot;WINSTON&quot;",
    "適應症": "老人性神經痛、急慢性僂麻質斯、肋間神經痛、痛風、坐骨神經痛、婦人腰痛、關節痛、外傷性神經痛、筋肉痛、手術後癒著痛、壓痛",
    "劑型": "270注射劑",
    "包裝": "20毫升安瓿裝，100支以下盒裝安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CHONDROITINSULFATESODIUM(EQTOSODIUMCHONDROITINSULFATE),SODIUMSALICYLATE"
    ],
    "限制項目": "01國　產",
    "申請商名稱": "1217820200  溫士頓醫藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1217820300  溫士頓醫藥股份有限公司",
        "製造廠廠址": "台南市永康區鹽洲里仁愛街１１７號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406000310",
            "成分名稱": "CHONDROITIN SULFATE SODIUM (EQ TO SODIUM CHONDROITIN SULFATE )",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808601600",
            "成分名稱": "SODIUM SALICYLATE",
            "含量描述": "",
            "含量": "400.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥製字第019330號仿單(僂麻鎮注射液)20140623-2014-08-13.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01019330&Seq=001&Type=9"
        }
    ]
}